Johnson & Johnson (JNJ) EBITDA margin US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EBITDA margin, % | ? | 24.6% | 27.4% | 23.1% | 25.3% | 34.5% | 34.4% | ||
Changes by years, y/y, % | -4pp | +3pp | -4pp | +2pp | +9pp | +4.5% |
Johnson & Johnson. EBITDA margin, %
Johnson & Johnson. EBITDA margin, changes, pp
Johnson & Johnson (JNJ) EBITDA margin US GAAP (quarter values) |
||||||||
2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q1 | LTM ? | |||
EBITDA margin, % | ? | 34.6% | 36.7% | 27.8% | 37.1% | 36.1% | 34.4% | |
Changes by years, y/y, % | +9pp | +10pp | +5pp | +2pp | +1pp | |||
Changes by quarters, q/q, % | 0pp | +2pp | -9pp | +9pp | -1pp |